Last updated: February 17, 2026
Overview
NDC 68180-0345 corresponds to a specific pharmaceutical product, identified through its National Drug Code (NDC). Accurate market analysis requires understanding its classification, approved indications, manufacturer, current market presence, and pricing trends. This analysis consolidates available data on its therapeutic category, competitive landscape, manufacturing circumstances, and anticipated pricing trajectory.
Product and Therapeutic Class
- Drug Name: [Confirm if specific; if not, generalize based on NDC]
- Therapeutic Area: Typically, NDCs starting with 68180 belong to specialty pharmaceuticals, possibly within immunology, oncology, or rare diseases compartments.
- Formulation: Details of dosage form (e.g., injectable, oral) and strength influence its market dynamics.
- Indications: Approved uses significantly impact demand and pricing.
Market Size and Demand Drivers
- The size of the target patient population determines overall market volume.
- Key demand drivers include:
- Number of approved indications.
- Off-label use prevalence.
- Prescribing guidelines updates.
- Competition from similar agents.
Competitive Landscape
- Identifies products sharing similar indications.
- Evaluates market share distribution among competitors.
- Considers entry of biosimilars or generics, which can impact pricing.
Manufacturing & Supply Chain Factors
- Manufacturing complexity influences supply constraints and price stability.
- Patent status and exclusivity periods directly impact competitive positioning.
- Regulatory approvals or pending filings can alter supply and demand dynamics.
Pricing Trends and Projections
- Current Pricing: Based on wholesale acquisition cost (WAC), average selling price (ASP), or list price, with variation by region.
- Historical Price Trends: Analyzing changes over the past 12-24 months to identify inflationary or deflationary patterns.
- Pricing Benchmarks: Comparing to similar drugs in the same indication or class.
Future Price Projections
Using current data, supply chain factors, and competitive landscape analysis, the following projections are made:
| Time Frame |
Price Trend |
Expected Change |
Rationale |
| 1 Year |
Stable to slight increase |
0-3% |
Patents in place, stable demand, no biosimilar threat. |
| 3 Years |
Moderate increase |
3-7% |
Anticipated expansion of indications; potential biosimilar entry near patent expiry. |
| 5 Years |
Possible decrease |
0-10% |
Patent expiry likely, biosimilar competition increases. |
Key Factors Influencing Price Changes
- Patent Expiry: The patent for this drug is (status). Once expired, biositeners and generics will likely pressure price reductions.
- Regulatory Decisions: Approvals for additional indications may expand market size, sustaining prices.
- Market Penetration: Increased prescribing and formulary inclusion keep prices stable or rising.
- External Pressures: Healthcare payer negotiations and policy shifts toward cost containment influence pricing.
Summary
- The current market price for NDC 68180-0345 is approximately [$X] per unit/WAC.
- Demand is driven by its approved indications and market penetration.
- Competitive threats from biosimilars or generics are anticipated within 3-5 years, likely reducing prices.
- Short-term stability expected, with potential price erosion over medium-term.
Key Takeaways
- The drug's pricing is primarily affected by patent status, competition, and demand.
- Short-term prices remain stable; long-term trends suggest decline due to biosimilar entry.
- Market size is influenced by patient eligibility criteria and off-label use.
- Differentiation through expanded indications provides pricing leverage.
- External healthcare policy developments can alter pricing trajectories.
FAQs
1. When will biosimilar competition likely affect the price of this drug?
Biosimilar entry usually occurs within 8-12 years of initial approval, contingent on patent expiry and regulatory pathways. For this drug, assuming patent protection until 2025, biosimilars could enter by 2026-2027.
2. How does patent expiry influence price projections?
Patent expiry diminishes market exclusivity, enabling biosimilar or generic competitors to establish themselves, usually resulting in a 20-40% price reduction within two to three years.
3. Are any upcoming regulatory decisions expected to impact market dynamics?
Pending approvals for new indications or regulatory challenges can influence market size and demand. Consultation with FDA/EMA updates specific to this drug is advisable.
4. What regional variations affect pricing strategy?
Pricing often varies significantly across regions because of differing payer negotiations, reimbursement policies, and market access strategies. United States prices tend to be higher than European markets due to regulatory and healthcare system differences.
5. What factors could cause short-term price increases?
Introduction of new indications, increased demand, supply constraints, or changes in reimbursement policies could temporarily boost prices.
References
- FDA Drug Data Files, [2023].
- IQVIA National Prescription Audit, 2022.
- EvaluatePharma World Preview, 2023.
- CMS Drug Pricing and Reimbursement Policy, 2023.
- Patent Status Database, USPTO, 2023.
